In silico modelling of biological pathways is a major endeavour of systems biology. Here we present a methodology for construction of pathway models from the literature and other sources using a biologistfriendly graphical modelling system. The pathway notation scheme, called mEPN, is based on the principles of the process diagrams and Petri nets, and facilitates both the graphical representation of complex systems as well as dynamic simulation of their activity. The protocol is divided into four sections: 1) assembly of the pathway in the yEd software package using the mEPN scheme, 2) conversion of the pathway into a computable format, 3) pathway visualisation and in silico simulation using the BioLayout Express 3D software, 4) optimisation of model parameterisation. This method allows reconstruction of any metabolic, signalling and transcriptional pathway as a means of knowledge management, as well as supporting the systems level modelling of their dynamic activity. 2010 [2, 3] and is presented here in its current form (Box 1). The scheme consists of entity nodes (which represent biochemical components), process nodes (which represent interactions between the components) and edges, which link entity and process nodes. Pathway maps can be drawn in the free graph editing software yED (yWorks, Tübingen, Germany; www.yworks.com). The bipartite (alternating entity and process node) nature of a pathway model drawn according to the rules of mEPN allows it to be parameterised for computational modelling as a Petri net (a mathematical approach for describing distributed systems, Box 2) by addition of tokens to chosen entry entity nodes in the pathway representing its initial state. When a mEPN model is imported into the open-source software BioLayout Express 3D , a simulation is performed that results in the flow of these tokens through the pathway and generation of quantitative outputs at each entity node that can be visualised as graphs of token flow over time. Altering the simulation parameters can change the flow of tokens, allowing the dynamics of pathways to be modelled under different conditions.
Introduction
The era of molecular biology has resulted in generation of vast amounts of data on biological processes ranging from in-depth studies of one or two molecules and their interactions, to large sets of omics data.
These data are currently dissipated in the literature and databases. Those new to a particular biological process or pathway may wish to start researching it through reviewing the primary literature or by reading reviews. However, biological pathways may not have a conventional beginning and end, and the linear prose of a literature review may struggle to present the information in an order that makes it easy to understand as a series of interrelated events. There is also potential for ambiguity as to the exact identity of components due to the frequent use of multiple names for same entity, some or all of which may not be their official names, as dictated by nomenclature committees. Visual representation of biological processes as pathway models can circumvent these issues by presenting the pathway to an end user, allowing them to decide what information is important or indeed missing. Pathway models should logically depict molecular interactions using standardised notation, unambiguously identify the pathway's components and their transition state, and be easily understood by a biologist. The ultimate goal of a good pathway model is the ability to use it in computational simulations to aid future hypothesis generation. Implementation of a system that fulfils these criteria benefits any scientist working in experimental biology and thus has a large potential user base. To this end, we have combined a proven, user friendly and unambiguous notation system with a Petri net based method of parameterising these models for computational simulation. The use of freely available software with which to construct and run these models makes computational modelling accessible to anyone with a computer and an internet connection.
The modified Edinburgh Pathway Notation (mEPN) scheme was first published in 2008 [1] , refined in The signal flow is represented by movement of tokens between nodes. The state of each node (network "marking") is determined by the number of tokens held by it. When a transition is enabled, it may be fired to remove a number of tokens from each input place equal to the weight of the connecting input arc, and create a number of new tokens at each output place equal to the weight of the connecting output arc.
The protocol described here results in dynamic models of biological pathways that will enrich the work of biologists. At their most basic they act as a graphical bibliography, with steps in the pathway hyperlinked to research papers or reports. When fully parameterised and run as dynamic models they can assist with hypothesis generation and identification of gaps in understanding of a particular biological process. In silico models can be used in tandem with wet-lab experiments and also have the potential to replace or at least refine them. Construction of dynamic pathway models is a useful tool in a biologist's skill-set and using mEPN and BioLayout Express 3D to construct signalling Petri nets means this is now within reach of all biologists, not just those with knowledge of mathematical modelling.
Experiment Design
First we describe how to construct a graphical model of a biological pathway using the mEPN scheme and then how to convert this graphical model into one that supports computational modelling of the system (steps 1-10). Next, we present how to run simulations and visualize system dynamics (steps 11-17). In the final section (steps 18-23) we describe how to optimise and validate a pathway model.
The workflow is shown schematically in Figure 1 . To illustrate our approach, we use a relatively simple model of interferon-β signaling, a cytokine pathway which plays an important role innate immunity. To illustrate how to overcome challenges that users may encounter we present a simulation of the interferon-β/SOCS1 feedback response to different doses of interferon-β.
Figure 1

Materials Equipment
A computer with a Windows, Apple Mac or Linux operating system, internet connection and a web browser with JavaScript enabled. The hardware configuration may limit the size of models that can be displayed within yEd, as well as when running pathway simulations within BioLayout Express 3D , where it will influence the speed of simulations and the frame rate for animations of flow. The general rule is that the better hardware, the faster the algorithms will run and smoother the user's interaction with a model. Recommended hardware for optimum performance are as follows: 
Software setup
Installation of yEd Graph editor
yEd is a free and intuitive software application that can be used to create high-quality network diagrams, it runs on all major platforms: Windows, Unix/Linux and Mac OS X. Download and install the latest release of the yEd Graph editor from the yWorks (Tübingen, Germany) website www.yworks.com.
 Troubleshooting
If you encounter any problems with the installation of yEd contact: support@yworks.com
Installation of BioLayout Express 3D
BioLayout Express 3D software allows the visualization and analysis of large network graphs in two and three-dimensional space and supports the computational modelling of networks using the signalling Petri net (SPN) algorithm [4] . BioLayout Express 3D runs on Windows, Mac OS X and Linux platforms. Java SE 6 or 7 is required and can be downloaded from http://www.java.com/getjava. There are two ways to run BioLayout Express 3D : 
BOX 3: Component annotation Component Annotation
For many molecular species multiple names are frequently employed to describe them. This is particularly the case for one of the main components of biological pathways, proteins. Any given protein may be referred to in the literature by a number of different names concurrently. The use of nonstandard nomenclature frequently leads to confusion in written texts and in diagrams the issue is often the same. If the naming of pathway components is not clear then uncertainty arises as to what exactly is being depicted in a diagram and it ends up representing little more than a series of abstract concepts.
Our models have generally been focused on human pathways and we have used standard Human Gene Nomenclature Committee (HGNC) names to label nodes representing genes and proteins. This We have used the excellent ChemSpider resource (www.chemspider.com/) as a reference for the naming biochemical entities although other resources e.g. ChEMBL (www.ebi.ac.uk/chembl/) are potentially equally good. Using the node properties dialogue (F6) nodes may be hyperlinked to external web resources and addition notes to nodes using in the Data tab within yEd.
Protein state:
The 
Protein complexes:
Names of the components are given as a concatenation of the proteins belonging to the complex separated by a colon. If the complex is commonly referred to by a generic name this may be shown below the constituent parts in rounded ( ) brackets.
Where a specific protein is present multiple times within a complex, this may be represented by placing the number of times a protein is present within the complex in angle brackets <n>.
A node representing a component may be coloured to impart visually information on component's type e.g. to differentiate between a protein and a complex.
Similarly other types of pathway components may be represented using a range of shapes and colours -see palette for list of glyphs used to represent different entity types.
A component may only be shown once in any given cellular compartment (in a given state As an example, see the list of components present in the interferon-β pathway (Figure 2A ). The sample Interferon_components.graphml file can be used in this step (Supplementary Data 2).
Draw the interactions between entity nodes. The nature of an interaction between
components may be represented using process nodes and edges.  Edges are lines that join entity and process nodes. Edges denote the type of interaction (activation, catalysis, inhibition) and their directionality establishes inputs and outputs from entity nodes. Edges function as the equivalent of Petri net 'arcs'.
In general and absolutely so when constructing a diagram to be used for computational modelling, nodes comprising a pathway should be arranged as a bipartite graph i.e. entity nodes should be connected exclusively via a process node and vice versa. This structure is the same structure used by Petri nets (places must be connected to transitions) and it is essential if the model is to be used for simulation experiments. is opened and the desired number of tokens is typed into the edge name (text) box ( Figure 2C ).
Token values can range from 0 to millions but in essence represent the relative amount or activity of a given component under initial conditions.
Ideally the initial parameters should be set with reference to some experimental data providing information on the relative initial concentrations of the pathway components where known.
However in the initial stages of pathway parameterisation it is often sufficient to place an arbitrary number of tokens on component just to check the connectivity between inputs and outputs is not compromised in any way. The dynamic behaviour of the pathway is then simulated by the movement of the tokens between entity nodes (token flow) by the algorithm executed within BioLayout Express 3D . o Original Transitions: tokens accumulate on input nodes where flow from them is blocked i.e. if there are two inputs into a transition and one has tokens and the other does not, tokens will not be lost from the input with tokens. This mode was as originally described by Ruths et al; [4] .
After selecting the options for running a flow simulation, press the 'Run the Simulation' button to initiate the computation of the SPN algorithm ( Figure 3B6 ). The time it takes to run a computation depends on the number of time blocks/runs, the size of the pathway model and hardware on which the simulation is run. However, for most small to medium size pathways and hardware configurations, the time taken is usually a few seconds or less.
Save the results.
Once the SPN simulation algorithm has finished, a Simulation Results dialogue appears ( Figure 3C ). At this point the results, token level per node per time block can be saved as a .txt or .spn file by ticking the "Save SPN Results" box or pressing ALT+S ( Figure   3C7 ). Saved simulation results files can be loaded pressing ALT+L back in the main window.
Results files can also be viewed as a spreadsheet e.g. in Excel. An mEPN model can also be exported as a Systems Biology Graphical Notation (SBGN) [5] diagram via File -> Export -> SBGN file. This can be opened in any SBGN compliant software e.g. VANTED with SBGN-ED add-on [6] .
Visualize token flow as node output graphs.
To visualize the simulation results for a selected entity/place node, close the SPN simulation results dialogue box ( Figure 3C8 Figure 3C8 ). Figure   3F ).
Control visualization of token flow in the Simulation Animation Control window (
 Node Animation:
Provides options to choose which nodes are animated and the type of animated transition that takes place between the node value associated with one time block and the next (F  Timing ( Figure 3E11 o Set (fixed) node value: the number of tokens required at which point the maximum node size and colour is represented. The default value for the 'Max value' is determined by the maximum number of tokens that accumulate at any given node during a simulation. It is often the case that some nodes accumulate tokens much in excess others e.g. when output is blocked. This can result in the majority of nodes seemingly to change little in size or colour during a simulation. By manually changing this value and checking the associated box, a user-defined value will be set and maintained for subsequent runs.
 Colour Palette Spectrum Transition (Figure 3E13) :
This dialogue provides options to control the changes in colour as node token values change.
A range of colour spectra are provided or can be user specified. 
Visualize token
Error checking.
Errors in a diagram's structure, predominately failure to adhere to the strict requirement for the maintenance of a bipartite graph or improper logic, can lead to bottlenecks in token flow. When the bipartite graph structure is not maintained e.g. an entity node is directly linked to another, the SPN algorithm cannot operate and tokens will accumulate on the node upstream of the issue and zero tokens will be passed on to subsequent nodes. To avoid bottlenecks users should check the reactions preceding any node whose token output is zero ( Figure 4A ) and correct mistakes as necessary.
BOX 4: Layout Optimisation
There is a part of pathway modelling that could be considered art, or at least creative cartography.
When starting a diagram the number of components is small and visual comprehension  Space can be organised effectively by structuring sub-pathways into modules.

Modules of the pathway should be arranged so that the connected glyphs are in close proximity, to minimise tangling of connective edges.
Hierarchical relationships between components should be shown in the layout of interactions.
In order to do this an orientation of pathway flow is chosen (e.g. left to right or top to bottom) and should be maintained throughout the diagram where possible.
However, each diagram is essentially unique and each comes with its own challenges. There is no one solution that fits all models and as diagrams so must adapt the layout to take in new components and concepts. 
End of the line.
At the end of any pathway is potentially a next, but as yet undefined, event or outcome. Without an output a component (place) at the end of a line of flow will simply accumulate tokens as there is nowhere for them to flow on to. For instance, a pathway may end at a gene which is shown to be up-regulated upon activation of the upstream signalling components but it will never turn off even if its activation stops. One approach to stop tokens accumulating at such sites is to place a 'pathway node' (a process node defined as a transition), after the gene indicating what the transcribed protein may go on to do. Tokens will then be lost from the system and not accumulate on the entity node representing the gene.
Some branches may end in a 'sink' process node signifying that a component is removed from Figure 4C ).
24.
Modelling negative feedback loops. Such regulatory systems are common and essential in biological systems limiting the degree to which a given process is activated. The network motif is common to many systems and involves the activation of a pathway component that goes on
to inhibit an earlier step in the process. The inhibition of the interferon-β receptor by SOCS1 whose genes is activated by the interferon signalling pathway represents such a negative feedback loop ( Figure 2 ). In order to represent an inhibitory activity such as this using the mEPN scheme, an inhibitor edge is placed from the inhibitor molecule to process node representing the step that is inhibited. During a simulation tokens will not be lost through an inhibitor edge. With no output an inhibitory node will accumulate tokens and will irrevocably block the transition to which it is connected. If a sink node is placed on an inhibitor molecule it serves to give the inhibitory molecule a 'half-life' (in practice any process node will serve the same purpose, but use of the sink node helps visually define the process involved). In the absence of further input into the inhibitor node, such as during the 'off phase' of negative feedback system, tokens will now be lost from the inhibitor. The result is that its inhibitory effect 
Anticipated Results
This protocol describes the generation of pathway models using the mEPN language for graphically representing biological systems. mEPN models can be used both as a resource to store and display what is known about a pathway and in turn converted to a computational model by setting parameters to define the initial state of the pathway. Using the sample interferon-β components GraphML file (Supplementary Data 2) a pathway model can be produced that represents events from the binding of interferon-β to its receptor and the signalling pathway leading the activation of target genes. The resulting model can be parameterised adding tokens to obtain a SPN-ready model, as provided in the sample interferon-β pathway GraphML file (Supplementary Data 3) . This is a relatively small diagram, to view and run larger pathway models go to: www.virtuallyimmune.com.
The BioLayout Express 3D software is fully compatible with the mEPN notation and can be used to for pathway visualization and to perform stochastic flow simulations using a modified version of SPN algorithm [4] . Running simulations provides insights into the dynamic behaviour of the system by enabling users to visualize the signal flow within the network. The signal flow is simulated by the accumulation of tokens at entity nodes (places) and can be visualized in 2D graphs or by 3D animation. The inflation and contraction of the entity nodes represents the accumulation and degradation of reactants in the pathway. In this way, complex biological processes with multiple components can be modelled.
The interferon-β signalling network -an oscillating feedback control system
Biological systems display a variety of dynamic behaviours ranging from stable steady states to oscillations. Oscillations in protein concentrations or gene expression levels are commonly associated with the presence of negative feedback loop(s) in the regulatory network [7] . Based on the analyses performed using this system many factors can affect the amplitude, frequency and stability of oscillations. For instance, the time-delay (path length) between token input and inhibitor, the type of inhibition edge used (competitive or non-competitive), the number of inhibitors present and their halflife will allow affect how a system containing a negative feedback loop will operate in practice.
As an example a simple model of the interferon-β signalling pathway is presented. Interferon-β is a cytokine released by immune cells in response to pathogens. It acts as an autocrine and paracrine signalling system that triggers the activation of host defence systems. In the form provided the model operates as a damped oscillator [8] , where low-dose IFN stimulation yields oscillations of lesser amplitude that are damped faster than those induced at a high-dose (Figure 5) . To reproduce these observations users can modify the token input or topology of the example file provided (Supplementary Data 3).
BOX 5: Glossary
 Arc: In Petri nets, arcs are directional edges that connect a place to a transition or vice versa, (but never between places or between transitions). Arcs are represented as edges in mEPN notation.
 Edge: In mEPN notation, edges are arrows used to connect entity and process nodes to indicate an interaction and also the interaction direction. The Petri net equivalent is an arc.
 Entity node: In mEPN notation, entity nodes are glyphs that represent model components such as molecules or genes. The Petri net equivalent is a place.
 Glyph: a visual representation of an entity, process or transition node.
 GraphML: a XML-based file format used to describe the structural properties of a graph.
 Layout: the way in which nodes and edges are set out in 2D or 3D space (physical topology).
 Model: the visual representation of a network.
 mEPN: modified Edinburgh Pathway Notation scheme is a graphical notation system based on the concepts of the process diagram.
 Network: a number of interconnected entities.
 Notation scheme: a system of symbols used to represent diverse biological entities and interactions in semantically and visually unambiguous manner.
 Parameterization: defining the initial state of the system by the placement of tokens.
 Petri net: is a directed bipartite graph that alternates places (entities) and transitions (events that occur).
 Place: In Petri nets, places represent possible states of the system. They are represented as entity nodes in mEPN notation.
 Process diagram: is a diagram used to give an abstract description of the behaviour of a system that represents changes of the state of each molecule using arrows that indicate transition.
 Process node: In mEPN notation, process nodes are glyphs that represent and define interactions between entities or the transition of an entity from one state to another. The Petri net equivalent is a transition.
 SPN: Signalling Petri net, a non-parametric model for characterizing the dynamics of signal flow through a signalling network using token distribution.
 Tokens: Tokens represent quantitative information that is introduced and distributed through a Petri net  Topology: arrangement of various elements of the pathway (nodes, edges, etc) that illustrates how information flows within the network.
 Transition: In Petri nets, transitions are events or actions. They are represented as process nodes in mEPN notation. 
